Eli Lilly and Company: Barry Wren
Barry Wren has been the Chief Financial Officer of South Africa and Sub-Saharan Africa at Eli Lilly and Company since April 2015.
Barry Wren was appointed CFO of Eli Lilly South Africa and Sub-Saharan Africa in April 2015. He was born and schooled in Zimbabwe and later moved to South Africa to study at Rhodes University. He has an H.Dip, majoring in Accounting and Commercial Law. He qualified as a Chartered Accountant (SA) with PwC, working in both Assurance and Transaction Services. Barry has spent the majority of his career in the healthcare industry working for companies like Covidien and Mallinckrodt Pharmaceuticals. He has experience in Finance, Business Development, Sales and Marketing, Human Resources and General Management.
2015 – Present Chief Financial Officer, Eli Lilly and Company, South Africa and Sub-Saharan Africa
2013 – 2015 Country Manager, Mallinckrodt Pharmaceuticals
2008 – 2013 Sales and Marketing Director, Covidien
2006 – 2008 Financial Director, Covidien
2004 – 2006 Manager: Financial Planning, Analysis and Reporting, Hewlett-Packard
2002 – 2004 Financial Manager, Covidien
1999 – 2002 Assistant Manager: Transaction Services, PwC
1999 – 2000 CA (SA), SAICA
1995 – 1999 H.Dip, Accounting, Taxation, Commercial Law, Rhodes University
1989 – 1994 A Levels, Christian Brothers College
About Eli Lilly and Company: Founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicine that met real needs. Eli Lilly and Company makes medicine that helps people live longer, healthier and more active lives.
In 2017 Eli Lilly and Company reported a revenue of $22.871 billion with 40 655 employees.